Sponsor Trial Liaison
STL
- Represent the sponsor
- Monitor the CRO / CRAs
- Main contact for investigators
- Conduct Site Initiation Visits (SIVs)
- Support patient enrollment
- Optimize study-time management
Integrated Solutions for Early-Stage Assets
subrosa designs, coordinates and delivers services across the critical stages from early scientific development to clinical-trial execution — shortening timelines and translating data into robust, compliant and investable development programs that de-risk assets at the critical transition into human studies.
We provide a capital-efficient globalization platform for early-stage and rare-disease assets, making them investable (preclinical), approvable and competitive (clinical), used and reimbursed (medical).
We support you to transform local preclinical programs into globally investable assets.
Preclinical services encompass the scientific, regulatory and strategic activities required to prepare a drug candidate for first-in-human testing. This phase bridges early discovery and clinical development by generating the safety, pharmacology and feasibility data needed to support regulatory engagements.
subrosa combines the knowledge, experience and insights of our clinical, medical, regulatory, market-access, commercial and capital units to help early biotechs and university spin-offs in the preclinical stage develop a global asset & regulatory strategy and the TPP design — to de-risk and prepare for global entry. Board- and investor-ready.
Our Global Networks across KOLs, C-suite leaders, capital sources and top talent give us direct access to potential co-development partners, grants, funding sources, executives and scientific & preclinical development management.
“We help to ensure your clinical program answers the questions regulators, payers and physicians actually care about.”
Many trials from startup and orphan-drug developers are optimized for regulatory approval, yet fall short of meeting reimbursement or physician expectations. The root causes often include a limited variety of inclusion criteria, endpoints that lack real-world relevance, and insufficient alignment with KOLs and payers.
subrosa Clinical Operations Services combine the knowledge, experience and insights of our clinical, medical, regulatory, market-access, commercial and capital units to bring medical-affairs and investor thinking early into clinical design.
Our integrated services support the originator’s clinical strategy, study design and study-site selection. Our rare-disease early patient genome database normally reveals additional symptoms (inclusion criteria) of young patients that have not been published so far. On that basis we recruit patients for trials through clinical programs in every market globally with a reliable outcome — patients in a development phase, years earlier than today’s standards. Where it makes sense, we develop biomarkers successfully (multiple proven) and deploy Sponsor Trial Liaison (STL) or Clinical Trial Medical Liaison (CTML) field teams, helping sponsors accelerate delivery while improving trial quality and readiness for later commercialization.
Our Global Networks across KOLs, C-suite leaders, capital sources and top talent give us direct access to medical, development and clinical-operations executives and management, as well as to potential co-development partners and funds.
Sponsor-deployed liaison teams to accelerate delivery and improve trial quality.
Two distinct field roles — complementary, with different mandates and timings.
Finding and engaging high-impact talent for key roles in your research, preclinical and clinical operations unit demands significant time and internal capacity — resources that are often better invested elsewhere. Our deep expertise in pharmaceutical and biotech recruitment positions us as a trusted partner to secure the specialized talent your organization depends on.
Using long-lasting relationships and a targeted, real-time recruitment model aligned with your requirements, we attract top-quality candidates quickly and effectively. From vacancy management to permanent recruitment and strategic leadership appointments, we ensure you receive the talent you need, precisely when you need it.
Trusted by leading life-science companies worldwide.
We don’t promise what we might not be able to keep.